Patient perceptions of multiple sclerosis and its treatment

por de Seze, Jérôme, Borgel, Florent, Brudon, Frédérique
Publicado 2012

A Case of Paraneoplastic Demyelinating Motor Polyneuropathy

por Mostoufizadeh, Sohrab, Souri, Maryam, de Seze, Jérôme
Publicado 2012

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis

por Chan, Andrew, de Seze, Jérôme, Comabella, Manuel
Publicado 2016

Assessing Autophagy in Sciatic Nerves of a Rat Model that Develops Inflammatory Autoimmune Peripheral Neuropathies

por Brun, Susana, Schall, Nicolas, Jeltsch-David, Hélène, de Sèze, Jérôme, Muller, Sylviane
Publicado 2017

Emotional experience is increased and emotion recognition decreased in multiple sclerosis

por Pfaff, Line, Gounot, Daniel, Chanson, Jean-Baptiste, de Seze, Jérôme, Blanc, Frédéric
Publicado 2021

Inflammatory-like presentation of CADASIL: a diagnostic challenge

por Collongues, Nicolas, Derache, Nathalie, Blanc, Frédéric, Labauge, Pierre, de Seze, Jérôme, Defer, Gilles
Publicado 2012

Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review

por Pinto, Ashwin A., De Seze, Jerome, Jacob, Anu, Reddel, Stephen, Yudina, Anna, Tan, Kevin
Publicado 2023

Induced Brain Plasticity after a Facilitation Programme for Autobiographical Memory in Multiple Sclerosis: A Preliminary Study

por Ernst, Alexandra, Botzung, Anne, Gounot, Daniel, Sellal, François, Blanc, Frédéric, de Seze, Jerome, Manning, Liliann
Publicado 2012

Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis

por Manceau, Philippe, Latarche, Clotilde, Pittion, Sophie, Edan, Gilles, de Sèze, Jérôme, Massart, Catherine, Debouverie, Marc
Publicado 2014

Chronic Bickerstaff’s encephalitis with cognitive impairment, a reality?

por Renaud, Mathilde, Aupy, Jérôme, Camuset, Guillaume, Collongues, Nicolas, Chanson, Jean-Baptiste, de Seze, Jérôme, Blanc, Frédéric
Publicado 2014

Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies: An Observational Study

por Bigaut, Kévin, Kremer, Laurent, Fabacher, Thibaut, Lanotte, Livia, Fleury, Marie-Celine, Collongues, Nicolas, de Seze, Jerome
Publicado 2021

Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD)

por Bigaut, Kévin, Achard, Sophie, Hemmert, Céline, Baloglu, Seyyid, Kremer, Laurent, Collongues, Nicolas, De Sèze, Jérôme, Kremer, Stéphane
Publicado 2019

FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis

por Kremer, Laurent, Taleb, Omar, Boehm, Nelly, Mensah-Nyagan, Ayikoe Guy, Trifilieff, Elisabeth, de Seze, Jérôme, Brun, Susana
Publicado 2019

Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica

por Chanson, Jean-Baptiste, Alame, Melissa, Collongues, Nicolas, Blanc, Frédéric, Fleury, Marie, Rudolf, Gabrielle, de Seze, Jérôme, Vincent, Thierry
Publicado 2013

Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis

por Clavelou, Pierre, Castelnovo, Giovanni, Pourcher, Valérie, De Sèze, Jerome, Vermersch, Patrick, Ben-Amor, Ali-Frederic, Savarin, Carine, Defer, Gilles
Publicado 2023

Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype

por Brochet, Bruno, Clavelou, Pierre, Defer, Gilles, De Seze, Jérôme, Louapre, Céline, Magnin, Eloi, Ruet, Aurélie, Thomas-Anterion, Catherine, Vermersch, Patrick
Publicado 2022

Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials

por Giovannoni, Gavin, Kappos, Ludwig, de Seze, Jerome, Hauser, Stephen L., Overell, James, Koendgen, Harold, Manfrini, Marianna, Wang, Qing, Wolinsky, Jerry S.
Publicado 2021

Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology

por Fujihara, Kazuo, Bennett, Jeffrey L., de Seze, Jerome, Haramura, Masayuki, Kleiter, Ingo, Weinshenker, Brian G., Kang, Delene, Mughal, Tabasum, Yamamura, Takashi
Publicado 2020

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study

por Bigaut, Kévin, Kremer, Laurent, Fabacher, Thibaut, Ahle, Guido, Goudot, Mathilde, Fleury, Marie, Gaultier, Claude, Courtois, Sylvie, Collongues, Nicolas, de Seze, Jérôme
Publicado 2022

Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic

por de Sèze, Jérôme, Maillart, Elisabeth, Gueguen, Antoine, Laplaud, David A., Michel, Laure, Thouvenot, Eric, Zephir, Hélène, Zimmer, Luc, Biotti, Damien, Liblau, Roland
Publicado 2023